Aptatargets

read more La entrada aptaTargets and Merck named finalists in 2025 European Lifestars Awards for transfer of neuroprotective drug ApTOLL se publicó primero en Aptatargets.

read more La entrada ApTOLL's secondary analysis data of APRIL 1b/2a trial published in 'Stroke' se publicó primero en Aptatargets.

La biofarmacéutica española aptaTargets anuncia un acuerdo con Merck, firmado en octubre de 2024, para el...

read more La entrada aptaTargets transferred ApTOLL to Merck se publicó primero en Aptatargets.

read more La entrada aptaTargets awarded with the Programa Cheque Innovación 2024 from the Community of Madrid se publicó primero en Aptatargets.

read more La entrada A new study shows the cerebroprotective effects of ApTOLL on mice with acute ischemic stroke se publicó primero en Aptatargets.

read more La entrada Preclinical studies validate the potential of ApTOLL to reduce inflammation and regenerate myelin in models of multiple sclerosis se publicó primero en Aptatargets.

Read more La entrada European Stroke Conference 2024 se publicó primero en Aptatargets.

read more La entrada aptaTargets CSO Macarena Hernández will speak at the 10th European Stroke Conference se publicó primero en Aptatargets.

read more La entrada aptaTargets secures €2.5 million from the EU to initiate the Phase 2b clinical trial in patients with ischemic stroke se publicó primero en Aptatargets.